International Journal of Clinical Oncology
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer
International Journal of Clinical Oncology - Tập 8 - Trang 162-167 - 2003
Background. Cancer patients are at high risk of developing a second cancer after the treatment of initial cancers. Understanding the characteristics of multiple primary cancer is important to establish an effective surveillance program for the early detection of second cancers.
Methods. We analyzed the cancer registry records from 1986 to 1995 at the Cancer Institute Hospital. The combination of...... hiện toàn bộ
Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan
International Journal of Clinical Oncology - Tập 24 - Trang 1498-1505 - 2019
Treatment modality of desmoid-type fibromatosis (DF) has changed from surgery with a wide surgical margin to conservative treatment. In this study, tumor characteristics of DF, transition of the treatment modality, and clinical outcome of surgical treatment were analyzed based on data obtained from the bone and soft tissue tumor registry established in Japan. Data were collected as registration da...... hiện toàn bộ
Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer
International Journal of Clinical Oncology - Tập 19 - Trang 1005-1010 - 2014
This study was conducted to evaluate the efficacy and safety of S-1 in patients with advanced non-small-cell lung cancer (NSCLC), receiving two or more prior chemotherapy regimens. S-1 was administered orally for 14 consecutive days, followed by a 7-day rest period. This treatment course was repeated until disease progression or intolerable toxicity occurred. From 2010 to 2012, 45 patients were en...... hiện toàn bộ
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study
International Journal of Clinical Oncology - Tập 23 - Trang 490-496 - 2018
FOLFOXIRI is now regarded as the chemotherapy regimen that offers the best platform for the treatment of colorectal cancer. However, the safety and efficacy of FOLFOXIRI + panitumumab has not been demonstrated. We conducted a phase I study to determine the recommended dose of FOLFOXIRI + panitumumab as first-line treatment for RAS wild-type metastatic colorectal cancer (mCRC). Patients received co...... hiện toàn bộ
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients
International Journal of Clinical Oncology - - 2018
In the double-blind, phase 3 PALOMA-3 study, palbociclib–fulvestrant significantly prolonged progression-free survival versus placebo–fulvestrant in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) metastatic breast cancer (MBC) whose disease had progressed on prior endocrine therapy. The present study evaluated the efficacy, safety, and phar...... hiện toàn bộ
Performance of three prognostic models in critically ill patients with cancer: a prospective study
International Journal of Clinical Oncology - Tập 25 Số 7 - Trang 1242-1249 - 2020
The aim of the study was to evaluate the performance of “Acute Physiology and Chronic Health Evaluation II” (APACHE-II), “Simplified Acute Physiology Score 3” (SAPS-3), and “APACHE-II Score for Critically Ill Patients with a Solid Tumor” (APACHE-IICCP) models in cancer patients admitted to ICU. Prospective cohort study of 414 patients with an active solid tumor. Discrimination was assessed by area...... hiện toàn bộ
Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients
International Journal of Clinical Oncology - - 2021
This study aimed to investigate risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients through a meta-analysis. A comprehensive retrieve of Chinese databases China National Knowledge Infrastructure, Wanfang Data, VIP Database and English databases PubMed, ScienceDirect, Embase and Cochrane library was conducted. The studies that meet the requirements for meta-analys...... hiện toàn bộ
Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment
International Journal of Clinical Oncology - - 2015
Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
International Journal of Clinical Oncology - Tập 23 - Trang 757-764 - 2018
Currently, there is no consensus regarding which patients with high-risk prostate cancer (PCa) would benefit the most by radical prostatectomy (RP). We aimed to identify patients with high-risk PCa who are treatable by RP alone. We retrospectively reviewed data on 315 patients with D’Amico high-risk PCa who were treated using RP without neoadjuvant or adjuvant therapy at the institutions of the Ya...... hiện toàn bộ
Tổng số: 2,377
- 1
- 2
- 3
- 4
- 5
- 6
- 10